rethinkPeptides Search
Menu
Study breakdown

The Pain Peptide Substance P Can Weaken the Blood-Brain Barrier — But Only Under Certain Conditions

evidence
The takeaway

Substance P reduced a key protective protein in human brain blood vessel cells, but only when the cell layer was immature — revealing that this neuropeptide's effects on the blood-brain barrier are context-dependent.

Confluence-dependent

Substance P only reduced the BBB protein occludin in immature cell layers — fully formed barriers were resistant to its effects

What the researchers found

Substance P reduced expression of the tight junction protein occludin in human brain endothelial cells, but only when cells were at low confluence — at full confluence, no effect was observed. SP acted exclusively through a truncated form of the NK-1 receptor and stimulated Erk2 phosphorylation without triggering inflammatory cytokines (IL-6, IL-8) or ICAM-1. SP also restored nitric oxide production in cells exposed to TNF-α. Importantly, SP did not trigger intracellular calcium release, indicating the truncated NK-1R signals differently from the full-length receptor.

Why it matters

The blood-brain barrier is critical for brain protection, and understanding how neuropeptides like Substance P regulate its permeability has implications for neurological diseases including multiple sclerosis, stroke, and brain tumors. The finding that SP's effects depend on cell state (confluence) adds important nuance for designing neuropeptide-targeted therapies.

The numbers in context

Occludin reduced at low confluence only · Erk2 phosphorylation activated · no IL-6/IL-8/ICAM-1 changes · NO production restored under TNF-α · no intracellular calcium release

How the study worked

Human brain microvascular endothelial cells (hCMEC/D3 line) were treated with Substance P at different confluence states. Researchers measured mRNA and protein expression of BBB-related genes (occludin), NK-1R receptor expression, Erk2 phosphorylation, inflammatory marker levels (IL-6, IL-8, ICAM-1), nitric oxide production under TNF-α challenge, and intracellular calcium signaling.

Who was studied

Human brain microvascular endothelial cell line (hCMEC/D3) in vitro

What this study cannot tell us

Single immortalized cell line (hCMEC/D3) that expresses only the truncated NK-1R, which may not represent the full spectrum of SP signaling in native brain endothelium. In vitro conditions cannot fully replicate the complex blood-brain barrier environment in vivo. The functional consequences of reduced occludin on actual BBB permeability were not directly measured.

How to read the evidence

This is an in vitro mechanistic study using a single human brain endothelial cell line. It provides detailed molecular insights into SP signaling at the BBB but represents early-stage laboratory evidence that requires in vivo validation.

When this study was published

Published in 2022, this study contributes to an evolving understanding of how neuropeptides regulate blood-brain barrier function, a topic of growing interest in neurological disease research.

The bigger picture

The blood-brain barrier is the brain's gatekeeper, and its disruption contributes to many neurological diseases. Substance P is one of several neuropeptides that may regulate barrier permeability, making NK-1 receptor antagonists (some of which are already approved drugs for nausea) potentially relevant to BBB-related conditions. The confluence-dependent finding suggests that barrier integrity and maturation state determine vulnerability to neuropeptide signaling.

Questions still open

  • Does the confluence-dependent effect of Substance P reflect what happens during BBB damage in neurological diseases, when the endothelial layer is disrupted?
  • Could NK-1 receptor antagonists (like aprepitant) help protect the blood-brain barrier during neuroinflammation?
  • How does the truncated NK-1R signal differently from the full-length receptor, and what does this mean for drug targeting?

Common questions

What is Substance P and why is it important?
Substance P is a neuropeptide — a small protein made by nerve cells — that plays key roles in pain signaling, inflammation, and blood vessel regulation. In this study, researchers found it can also affect the blood-brain barrier, the protective shield that controls what enters the brain from the bloodstream.
Why does it matter that the effect only happened at low confluence?
Cell confluence refers to how completely cells cover a surface. At low confluence, cells haven't formed a tight barrier yet — similar to a damaged or developing BBB. The finding suggests Substance P may be most harmful to the blood-brain barrier when it's already weakened, which is exactly what happens during brain injury or neurological diseases.

Read the original research

Effects of substance P on human cerebral microvascular endothelial cell line hCMEC/D3 are mediated exclusively through a truncated NK-1 receptor and depend on cell confluence.

Neuropeptides, 95, 102265

Citation

Gao, Xin; Frakich, Nanci; Filippini, Perla; Edwards, Laura J; Vinkemeier, Uwe; Gran, Bruno; Tanasescu, Radu; Bayraktutan, Ulvi; Colombo, Sergio; Constantinescu, Cris S. (2022). Effects of substance P on human cerebral microvascular endothelial cell line hCMEC/D3 are mediated exclusively through a truncated NK-1 receptor and depend on cell confluence.. Neuropeptides, 95, 102265. https://doi.org/10.1016/j.npep.2022.102265